Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M313879200 on January 23, 2004

J. Biol. Chem., Vol. 279, Issue 17, 17792-17800, April 23, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/17/17792    most recent
M313879200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chuang, J. L.
Right arrow Articles by Chuang, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chuang, J. L.
Right arrow Articles by Chuang, D. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural and Biochemical Basis for Novel Mutations in Homozygous Israeli Maple Syrup Urine Disease Patients

A PROPOSED MECHANISM FOR THE THIAMIN-RESPONSIVE PHENOTYPE*

Jacinta L. Chuang{ddagger}§, R. Max Wynn§, Clint C. Moss{ddagger}, Jiu-li Song{ddagger}, Jun Li{ddagger}, Nibal Awad||, Hanna Mandel||**, and David T. Chuang{ddagger}¶**

From the Departments of {ddagger}Biochemistry and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390 and ||Metabolic Unit, Meyers Children's Hospital, Rambam Medical Center, Technion Faculty of Medicine, Haifa 31906, Israel

Maple syrup urine disease (MSUD) results from mutations affecting different subunits of the mitochondrial branched-chain {alpha}-ketoacid dehydrogenase complex. In this study, we identified seven novel mutations in MSUD patients from Israel. These include C219W-{alpha} (TGC to TGG) in the E1{alpha} subunit; H156Y-{beta} (CAT to TAT), V69G-{beta} (GTT to GGT), IVS 9 del[-7:-4], and 1109 ins 8bp (exon 10) in the E1{beta} subunit; and H391R (CAC to CGC) and S133stop (TCA to TGA) affecting the E2 subunit of the branched-chain {alpha}-ketoacid dehydrogenase complex. Recombinant E1 proteins carrying the C219W-{alpha} or H156Y-{beta} mutation show no catalytic activity with defective subunit assembly and reduced binding affinity for cofactor thiamin diphosphate. The mutant E1 harboring the V69G-{beta} substitution cannot be expressed, suggesting aberrant folding caused by this mutation. These E1 mutations are ubiquitously associated with the classic phenotype in homozygous-affected patients. The H391R substitution in the E2 subunit abolishes the key catalytic residue that functions as a general base in the acyltransfer reaction, resulting in a completely inactive E2 component. However, wild-type E1 activity is enhanced by E1 binding to this full-length mutant E2 in vitro. We propose that the augmented E1 activity is responsible for robust thiamin responsiveness in homozygous patients carrying the H391R E2 mutation and that the presence of a full-length mutant E2 is diagnostic of this MSUD phenotype. The present results offer a structural and biochemical basis for these novel mutations and will facilitate DNA-based diagnosis for MSUD in the Israeli population.


Received for publication, December 18, 2003 , and in revised form, January 23, 2004.

* This work was supported by National Institutes of Health Grant DK26758 and Welch Foundation Grant I-1286. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

** To whom correspondence may be addressed. E-mail: david.chuang{at}utsouthwestern.edu; or h_mandel{at}rambam.health.gov.il.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
D. T. Chuang, J. L. Chuang, and R. M. Wynn
Lessons from Genetic Disorders of Branched-Chain Amino Acid Metabolism
J. Nutr., January 1, 2006; 136(1): 243S - 249S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Mitsubuchi, M. Owada, and F. Endo
Markers Associated with Inborn Errors of Metabolism of Branched-Chain Amino Acids and Their Relevance to Upper Levels of Intake in Healthy People: An Implication from Clinical and Molecular Investigations on Maple Syrup Urine Disease
J. Nutr., June 1, 2005; 135(6): 1565S - 1570S.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Li, R. M. Wynn, M. Machius, J. L. Chuang, S. Karthikeyan, D. R. Tomchick, and D. T. Chuang
Cross-talk between Thiamin Diphosphate Binding and Phosphorylation Loop Conformation in Human Branched-chain {alpha}-Keto Acid Decarboxylase/Dehydrogenase
J. Biol. Chem., July 30, 2004; 279(31): 32968 - 32978.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement